Starting July 1, CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed ...

From the right: Dems at a Loss To Stop Trump Democrats today are “engaged in bitter infighting and struggling to come up with a unified strategy to oppose Trump,” observes The Washington Times ...

Pro & College Sports Pacers official tells ESPN to stop filming emotional player after loss Updated: Jun. 23, 2025, 10:02 a.m. | Published: Jun. 23, 2025, 8:39 a.m.

Pacers staffer tells ESPN to stop filming an emotional T.J. McConnell after Game 7 loss in NBA Finals Story by Chris Cwik Contributing writer Mon, Jun 23, 2025 · ...

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new analysis finds. Newer medications, such as Mounjaro and Wegovy, exhibit both ...

Earlier this year, Blue Cross Blue Shield said five GLP-1 drugs now account for nearly 20% of its pharmacy spend.

Blue Cross Blue Shield of Massachusetts says it will soon stop covering popular drugs for weight loss, like Ozempic and Wegovy. The medications have skyrocketed in price and popularity, but they ...

Former Playboy model Kendra Wilkinson revealed she stopped taking a weight-loss medication after being body-shamed by internet trolls.

Nationwide CFO Tim Frommeyer explains the get-big-or-get-out strategy behind the $1.25B acquisition of an Allstate niche product.

While interacting with Kiel, a deputy said they observed several indicators of criminal activity, prompting a search of the vehicle.

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now that the GLP-1 drug shortage has ended. People who rely on compounded GLP ...